Other genturis
* ERN GENTURIS uses AGREE II as a tool for the endorsement of guidelines. The quality of the guideline is evaluated through assessing the rigor and transparency of the guideline development process. The content of the guideline is not evaluated.
Von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance
Authors: Marie Louise M Binderup et al.
European Journal of Medical Genetics. 2022 Jun 13;65(8):104538. doi: 10.1016/j.ejmg.2022.104538.
Endorsed in June 2022
A guideline for the clinical management of basal cell naevus syndrome (Gorlin–Goltz syndrome)
Authors: Babette J.A. Verkouteren et al.
British Journal of Dermatology (Feb 2022); 186(2): 215-226. doi: 10.1111/bjd.20700.
Endorsed in June 2022
Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group
Authors: Bakhuizen et al.
Familial Cancer (Jun 2021); 20: 337–348. doi: 10.1007/s10689-021-00264-y.
Endorsed in April 2021
Hereditary diffuse gastric cancer: updated clinical practice guidelines
Authors: Vanessa R Blair et al.
Lancet Oncology (Aug 2020); 21(8): e386-e397. doi: 10.1016/S1470-2045(20)30219-9.
Endorsed in October 2020
Endorsed in March 2020